☆ 4.6 Editorial Material

Drugs without benefits? Confronting the challenges of drug-induced interstitial lung disease

THORAX (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Respiratory System

Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case-control study

Taisuke Jo et al.

Summary: The study identified six drug categories significantly associated with an increased occurrence of DILD, including epidermal growth factor receptor inhibitors and class III antiarrhythmic drugs, while statins were associated with a reduced risk of DILD. The findings provide valuable information for physicians to prevent and treat DILD.

THORAX (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting

Eiko Iwasa et al.

DRUG SAFETY (2020)

添加到收藏夹

Review Medicine, General & Internal

Drug-Induced Interstitial Lung Disease: A Systematic Review

Sarah Skeoch et al.

JOURNAL OF CLINICAL MEDICINE (2018)

添加到收藏夹

Article Respiratory System

Interstitial lung disease associated with gemcitabine: A Japanese retrospective cohort study

Tsuyoshi Hamada et al.

RESPIROLOGY (2016)

添加到收藏夹

Article Critical Care Medicine

Drug-Associated Acute Lung Injury A Population-Based Cohort Study

Rajanigandha Dhokarh et al.

CHEST (2012)

添加到收藏夹

Review Respiratory System

Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches

Osamu Matsuno

RESPIRATORY RESEARCH (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.